4-Chlorophenylacetonitrile

We are 4-Chlorophenylacetonitrile CAS:140-53-4 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

CAS No: 140-53-4
Product Name: 4-Chlorophenylacetonitrile
Other Name:
4-Chlorophenylacetonitrile
4-Chlorobenzyl Cyanide
2-(4-Chlorophenyl)acetonitrile
(4-Chlorophenyl)acetonitrile
 
Density: 1.2±0.1 g/cm3
Boiling Point: 266.0±0.0 °C at 760 mmHg
Melting Point: 25-28 °C(lit.)
Molecular Formula: C8H6ClN
Molecular Weight: 151.593
Flash Point: 107.7±15.4 °C
Exact Mass: 151.018875
PSA: 23.79000
LogP: 2.04
Vapour Pressure: 0.0±0.5 mmHg at 25°C
Index of Refraction: 1.549
 
Specification
Appearance: Colorless to pale yellow solid or liquid
Assay: ≥99.0%
Water: ≤0.2%
p-chlorotoluene: ≤0.2%
p-chlorobenzyl chloride: ≤0.3%
Chloride benzyl cyanide: ≤0.3%
 
Application
Intermediates of Pyrimethamine CAS: 58-14-0.
Intermediates of Phenvalerate CAS: 51630-58-1.
Be used as pesticide and pharmaceutical intermediate.
Parachlorobenzyl, or p-chlorobenzoacetonitrile, is an intermediate for the preparation of 3-methyl-2- (4-chlorophenyl) butanoic acid. It can be used to prepare pyrethroids such as fenvalerate, deltamethrin and other pyrethroids. Agent. Intermediate of the drug pyrimethamine, used in the manufacture of p-chlorobenzyl alcohol, p-chlorobenzaldehyde, p-chlorophenylacetonitrile, etc.
 
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.

4-Chlorophenylacetonitrile


Related News: As proof-of-principle for the unique advantages arising from selecting a single engineered iPSC clone for the production of CAR T-cell therapy, the scientists assessed 747 clones after engineering a pool of cells using CRISPR. It was found that only about 2% of clones met the Company’s standards for overall quality including containing both bi-allelic disruption of the TCR, proper insertion of the CAR into the TRAC locus without random transgene integrations, and no evidence of off-target genomic modifications or translocations.5-(4-(2-(5-Ethylpyridin-2-yl)ethoxy)benzylidene)thiazolidine-2,4-dione As proof-of-principle for the unique advantages arising from selecting a single engineered iPSC clone for the production of CAR T-cell therapy, the scientists assessed 747 clones after engineering a pool of cells using CRISPR. It was found that only about 2% of clones met the Company’s standards for overall quality including containing both bi-allelic disruption of the TCR, proper insertion of the CAR into the TRAC locus without random transgene integrations, and no evidence of off-target genomic modifications or translocations.70-53-1 On the basis of achieving low-cost and high-quality processes, production capacity will become the core driving force for API companies to break through sales bottlenecks.35092-89-8 On the basis of achieving low-cost and high-quality processes, production capacity will become the core driving force for API companies to break through sales bottlenecks.The injection has previously proven to be as effective as standard daily pills with three active ingredients when administered monthly and also once every two months.

Related Products
Product Name
6-bromo-13,13-dimethyl-11-phenyl-13H-indeno[1,2-b]anthracene View Details
3-(4-chlorophenyl)pentanedioic acid View Details
1-Bromopyrene View Details
Ethyl 6-fluoro-1-methyl-4-oxo-7-(1-piprazinyl)-4H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylate manufacturer 4-Bromo-2-fluoropyridine manufacturer 4-Methoxy-2-(trifluoromethyl)benzoic acid manufacturer 3-BROMO-2-FLUORO-4-IODOPYRIDINE manufacturer BIS(PENTAFLUOROPHENYL)CARBONATE manufacturer